Iron Deficiency Anemia (IDA) and the Brain
Public ClinicalTrials.gov record NCT05929729. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Neurovascular and Neurocognitive Consequences of Iron Deficiency Anemia
Study identification
- NCT ID
- NCT05929729
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Children's Hospital Los Angeles
- Other
- Enrollment
- 120 participants
Conditions and interventions
Interventions
- Ferric derisomaltose Drug
- NovaFerrum Drug
Drug
Eligibility (public fields only)
- Age range
- 16 Years to 60 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 6, 2023
- Primary completion
- Aug 31, 2028
- Completion
- Aug 31, 2028
- Last update posted
- Oct 29, 2024
2023 – 2028
United States locations
- U.S. sites
- 4
- U.S. states
- 1
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope Blood Donor Center | Duarte | California | 91010 | Not yet recruiting |
| Cedar Sinai Blood Bank | Los Angeles | California | 90027-6062 | Not yet recruiting |
| Children's Hospital Los Angeles | Los Angeles | California | 90027 | Recruiting |
| University of California, Los Angeles Blood Donor Center | Los Angeles | California | 90095 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05929729, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 29, 2024 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05929729 live on ClinicalTrials.gov.